Merck Long Term Debt 2010-2024 | MKKGY
Merck long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
- Merck long term debt for the quarter ending June 30, 2024 was $8.424B, a 18.64% decline year-over-year.
- Merck long term debt for 2023 was $9.999B, a 3.16% increase from 2022.
- Merck long term debt for 2022 was $9.693B, a 0.93% decline from 2021.
- Merck long term debt for 2021 was $9.784B, a 12.46% decline from 2020.
Merck Annual Long Term Debt
(Millions of US $) |
| 2023 |
$9,999 |
| 2022 |
$9,693 |
| 2021 |
$9,784 |
| 2020 |
$11,177 |
| 2019 |
$9,681 |
| 2018 |
$7,890 |
| 2017 |
$9,080 |
| 2016 |
$9,748 |
| 2015 |
$10,671 |
| 2014 |
$4,734 |
| 2013 |
$4,327 |
| 2012 |
$4,324 |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Long Term Debt
(Millions of US $) |
| 2024-06-30 |
$8,424 |
| 2024-03-31 |
$8,493 |
| 2023-12-31 |
$9,999 |
| 2023-09-30 |
$10,383 |
| 2023-06-30 |
$10,353 |
| 2023-03-31 |
$9,831 |
| 2022-12-31 |
$9,693 |
| 2022-09-30 |
$9,333 |
| 2022-06-30 |
$9,988 |
| 2022-03-31 |
$9,299 |
| 2021-12-31 |
$9,784 |
| 2021-09-30 |
$9,664 |
| 2021-06-30 |
$10,508 |
| 2021-03-31 |
$10,852 |
| 2020-12-31 |
$11,177 |
| 2020-09-30 |
$69 |
| 2020-06-30 |
$11,100 |
| 2020-03-31 |
$11,183 |
| 2019-12-31 |
$9,681 |
| 2019-09-30 |
$9,579 |
| 2019-06-30 |
$7,303 |
| 2019-03-31 |
$5,732 |
| 2018-12-31 |
$7,890 |
| 2018-09-30 |
$8,249 |
| 2018-06-30 |
$9,648 |
| 2018-03-31 |
$9,755 |
| 2017-12-31 |
$9,080 |
| 2017-09-30 |
$9,481 |
| 2017-06-30 |
$8,966 |
| 2017-03-31 |
$8,911 |
| 2016-12-31 |
$9,748 |
| 2016-09-30 |
$9,581 |
| 2016-06-30 |
$10,494 |
| 2016-03-31 |
$10,217 |
| 2015-12-31 |
$10,671 |
| 2015-09-30 |
$10,190 |
| 2015-06-30 |
$7,609 |
| 2015-03-31 |
$8,159 |
| 2014-12-31 |
$4,734 |
| 2014-09-30 |
$2,868 |
| 2014-06-30 |
$2,657 |
| 2014-03-31 |
$2,628 |
| 2013-12-31 |
$4,327 |
| 2013-09-30 |
$4,338 |
| 2013-06-30 |
$4,314 |
| 2013-03-31 |
$4,445 |
| 2012-12-31 |
$4,324 |
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
|
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
